help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mascia, F.
Right arrow Articles by Pastore, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mascia, F.
Right arrow Articles by Pastore, S.
(American Journal of Pathology. 2003;163:303-312.)
© 2003 American Society for Investigative Pathology

Blockade of the EGF Receptor Induces a Deranged Chemokine Expression in Keratinocytes Leading to Enhanced Skin Inflammation

Francesca Mascia, Valentina Mariani, Giampiero Girolomoni and Saveria Pastore

From the Laboratory of Immunology, Istituto Dermopatico dell’Immacolata, Istituto di Ricovero e Cura a Carottere Scientifico, Rome, Italy

During inflammatory skin disorders such as psoriasis, atopic dermatitis, and allergic contact dermatitis, epidermal keratinocytes overexpress large amounts of soluble epidermal growth factor receptor ligands in response to tumor necrosis factor {alpha} and interferon {gamma}. These cytokines also promote de novo synthesis of numerous chemokines, including CCL2/MCP-1, CCL5/RANTES, CXCL10/IP-10, and CXCL8/IL-8, in turn responsible for the recruitment of different leukocyte populations. This study demonstrates that stimulation of EGFR down-regulates CCL2, CCL5, and CXCL10, while it increases CXCL8 expression in keratinocytes. Conversely, EGFR signaling blockade produces opposite effects, with increased CCL2, CCL5, and CXCL10, and reduced CXCL8 expression. In a mouse model of contact hypersensitivity, a single topical administration of a selective EGFR kinase blocker before antigen challenge results in a markedly enhanced immune response with increased chemokine expression and heavier inflammatory cell infiltrate. Targeting EGFR on epithelial cells may thus have profound impact on inflammatory and immune responses.





This article has been cited by other articles:


Home page
JCOHome page
P. A. Gerber, E. Enderlein, and B. Homey
The Koebner-Phenomenon in Epidermal Growth Factor Receptor Inhibitor-Induced Cutaneous Adverse Effects
J. Clin. Oncol., June 1, 2008; 26(16): 2790 - 2792.
[Full Text] [PDF]


Home page
Arch DermatolHome page
V. Sans, T. Jouary, T. Hubiche, D. Smith, B. Milpied, and A. Taieb
Baboon Syndrome Induced by Cetuximab
Arch Dermatol, February 1, 2008; 144(2): 272 - 274.
[Full Text] [PDF]


Home page
J. Cell Biol.Home page
A. H. Shah, N. L. Cianciola, J. L. Mills, F. D. Sonnichsen, and C. Carlin
Adenovirus RID{alpha} regulates endosome maturation by mimicking GTP-Rab7
J. Cell Biol., December 3, 2007; 179(5): 965 - 980.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Scope, A. L. C. Agero, S. W. Dusza, P. L. Myskowski, J. A. Lieb, L. Saltz, N. E. Kemeny, and A. C. Halpern
Randomized Double-Blind Trial of Prophylactic Oral Minocycline and Topical Tazarotene for Cetuximab-Associated Acne-Like Eruption
J. Clin. Oncol., December 1, 2007; 25(34): 5390 - 5396.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. H. Heijink, P. M. Kies, H. F. Kauffman, D. S. Postma, A. J. M. van Oosterhout, and E. Vellenga
Down-Regulation of E-Cadherin in Human Bronchial Epithelial Cells Leads to Epidermal Growth Factor Receptor-Dependent Th2 Cell-Promoting Activity
J. Immunol., June 15, 2007; 178(12): 7678 - 7685.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
S. Segaert and E. Van Cutsem
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors
Ann. Onc., September 1, 2005; 16(9): 1425 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Pastore, F. Mascia, F. Mariotti, C. Dattilo, V. Mariani, and G. Girolomoni
ERK1/2 Regulates Epidermal Chemokine Expression and Skin Inflammation
J. Immunol., April 15, 2005; 174(8): 5047 - 5056.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. D. Woodworth, E. Michael, D. Marker, S. Allen, L. Smith, and M. Nees
Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment
Mol. Cancer Ther., April 1, 2005; 4(4): 650 - 658.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
N. Bhagavathula, K. C. Nerusu, G. J. Fisher, G. Liu, A. B. Thakur, L. Gemmell, S. Kumar, Z. H. Xu, P. Hinton, N. Tsurushita, et al.
Amphiregulin and Epidermal Hyperplasia: Amphiregulin Is Required to Maintain the Psoriatic Phenotype of Human Skin Grafts on Severe Combined Immunodeficient Mice
Am. J. Pathol., April 1, 2005; 166(4): 1009 - 1016.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Shirasawa, S. Sugiyama, I. Baba, J. Inokuchi, S. Sekine, K. Ogino, Y. Kawamura, T. Dohi, M. Fujimoto, and T. Sasazuki
Dermatitis due to epiregulin deficiency and a critical role of epiregulin in immune-related responses of keratinocyte and macrophage
PNAS, September 21, 2004; 101(38): 13921 - 13926.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al.
Functional Genomics of Lung Disease
Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81.
[Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
S. Blanchet, K. Ramgolam, A. Baulig, F. Marano, and A. Baeza-Squiban
Fine Particulate Matter Induces Amphiregulin Secretion by Bronchial Epithelial Cells
Am. J. Respir. Cell Mol. Biol., April 1, 2004; 30(4): 421 - 427.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.